StonvexLoading…
StonvexStonvexStonvexCore line items from TTAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $960.97M | $771.88M | $614.34M | $467.73M |
Operating Income | $-169.21M | $-229.95M | $-182.86M | $-221.86M |
Net Income | $-159.85M | $-239.09M | $-195.15M | $-269.52M |
EPS (Diluted) | $-1.73 | $-8.53 | $-7.24 | $-9.31 |
Total Assets | $1.75B | $1.77B | $1.52B | Not available |
Total Liabilities | $219.82M | $314.06M | $366.11M | Not available |
Cash & Equivalents | $428.77M | $441.80M | $146.71M | $202.49M |
Free Cash Flow OCF − CapEx | $105.43M | $33.25M | $-68.06M | $-194.71M |
Shares Outstanding | 92.38M | 42.15M | 33.27M | 30.41M |